Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  soy protein isolate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 04-08-09-04, NCT00245518
Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432
Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
Phase: Phase III
Type: Prevention
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: PRP1, CAN-NCIC-PRP1, CDR0000310096, NCT00064194
Phase II Trial of Dietary Fatty Acids: Roles in Hormonally Mediated Cancers in Normal Premenopausal Women (Summary Last Modified 06/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: 18-35
Sponsor: NCI
Protocol IDs: UMN-9509M10234, NCI-P97-0108
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Postmenopausal (20 and over)
Sponsor: NCI, Other
Protocol IDs: CDR0000069219, U10CA076001, CALGB-79805, NCI-P02-0206, NCT00031720
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000446088, P30CA022453, WSU-D-2325, NCT00243048
Soy Protein and Breast Cancer Risk Reduction
Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 40
Sponsor: Other
Protocol IDs: 02-422, Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, M01RR000073, 1UL1RR029876-01, NCT00204477
Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000466317, CCCWFU-98203, CCCWFU-BG03-332, NCT00345813
Phase I Randomized Study of Genistein for Prevention of Cancer in Patients With No History of Cancer or With Asymptomatic Early Prostate Cancer or Other Malignancy
Phase: Phase I
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-98-C-0099B
Dietary Intervention Study of Low-Fat Diet, Fish Oil, and Soy Supplements in Breast Cancer Patients
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCLA-HSPC-9508339, NCI-V96-0940
Start Over